Regeneron's Eylea improves vision in diabetic eye condition
(Reuters) - Regeneron Pharmaceuticals Inc's Eylea significantly improved vision in patients with diabetic macular edema (DME) compared to laser surger...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/L0G6FOKKEyk/story01.htm
No comments:
Post a Comment